Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,870
Out of 4,876 analysts
18
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $2.20 | +718.18% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $22.12 | -23.15% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $2.77 | +1,127.44% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $103.36 | -8.09% | 2 | Nov 1, 2022 | |
| SAGE Sage Therapeutics | Initiates: Hold | $41 | $9.14 | +348.58% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.94 | -31.97% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $33 | $0.30 | +11,086.44% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.75 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $3.79 | +744.33% | 4 | Dec 16, 2020 |
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $2.20
Upside: +718.18%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $22.12
Upside: -23.15%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $2.77
Upside: +1,127.44%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $103.36
Upside: -8.09%
Sage Therapeutics
Nov 1, 2022
Initiates: Hold
Price Target: $41
Current: $9.14
Upside: +348.58%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.94
Upside: -31.97%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $33
Current: $0.30
Upside: +11,086.44%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.75
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $3.79
Upside: +744.33%